In conversation with... James Alexander episode artwork

EPISODE · Oct 6, 2022 · 13 MIN

In conversation with... James Alexander

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.

NOW PLAYING

In conversation with... James Alexander

0:00 13:48

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 13 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on October 6, 2022.

What is this episode about?

James Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease.

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!